Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.

Abstract

OBJECTIVES:

To determine the relationship between serum lipid levels and the incidence of coronary events in older Japanese hypercholesterolemic patients without prior coronary heart disease (CHD).

DESIGN:

Post hoc subanalysis of the results in the Japan Lipid Intervention Trial.

SETTING:

A large-scale cohort observational study conducted throughout Japan.

PARTICIPANTS:

Men aged 35 to 70 and postmenopausal women younger than 70 with serum total cholesterol (TC) level of 220 mg/dL or greater treated for 6 years with low-dose simvastatin (52,421 total patients). After exclusion of 5,127 patients because of prior CHD and 4,934 patients because of incomplete data, 42,360 patients were divided into an older (9,860 patients, aged 65-70, mean age 67.1) and younger (32,500 patients, younger than 65, mean age 54.9) group and analyzed.

MEASUREMENTS:

Fasting serum lipid levels were measured every 6 months. Major coronary events, including fatal or nonfatal myocardial infarction, and sudden cardiac death as the primary endpoint and other cardiovascular diseases, including onset of angina pectoris, cerebrovascular events, and any causes of death, as the secondary endpoints were monitored.

RESULTS:

Simvastatin treatment in older patients was as safe and effective as in younger patients. Incident rates of major coronary events were 1.30 per 1,000 patient-years in the older group and 0.80 per 1,000 patient-years in the younger group. The incidence of a major coronary event was correlated to serum TC and low-density lipoprotein cholesterol (LDL-C) levels in both groups. The absolute risk of major coronary events in the older group was higher than in the younger group at any level of LDL-C, whereas the relative risk increased by 1.7% with an elevation of each 1 mg/dL LDL-C level in both groups. In the older group, the risk of major coronary events also increased as triglyceride level increased, whereas the risk decreased as high-density lipoprotein cholesterol level increased above 60 md/dL.

CONCLUSION:

The LDL-C level-dependent increase of relative risk of CHD was similar in elderly and younger patients, whereas the absolute risk at any LDL-C level in elderly patients was higher than in younger patients.

• Authors: Hisanori Horiuchi, Toru Kita, Hiroshi Mabuchi, Masunori Matsuzaki, Yuji Matsuzawa, Noriaki Nakaya, Shinichi Oikawa, Yasushi Saito, Jun Sasaki, Kazuaki Shimamoto, Hiroshige Itakura, J-LIT Study Group
• Journal: Journal of the American Geriatrics Society (J Am Geriatr Soc) Vol. 52 Issue 12 Pg. 1981-7 (Dec 2004) ISSN: 0002-8614 [Print] United States
• PMID: 15571531 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anticholesteremic Agents
• Lipids
• Simvastatin

Topics

• Adult
• Age Distribution
• Aged
• Anticholesteremic Agents (adverse effects, therapeutic use)
• Asian (statistics & numerical data)
• Cardiovascular Diseases (blood, epidemiology, prevention & control)
• Cerebrovascular Disorders (blood, epidemiology, prevention & control)
• Coronary Disease (blood, epidemiology, prevention & control)
• Female
• Hawaii (epidemiology)
• Humans
• Hypercholesterolemia (blood, drug therapy, epidemiology)
• Incidence
• Japan (ethnology)
• Lipids (blood)
• Male
• Middle Aged
• Proportional Hazards Models
• Risk
• Simvastatin (adverse effects, therapeutic use)
• Survival Analysis